Descriptive analysis of the Nationwide START2 antiphospholipid registry: Clinical and laboratory characteristics of patients with persistently positive antiphospholipid antibodies [0.03%]
中国START2抗磷脂综合征注册登记研究描述性分析：持续性抗磷脂抗体阳性患者的临床及实验室特征分布
Vittorio Pengo,Daniela Poli,Luca Sarti et al.
Vittorio Pengo et al.
Background: The clinical significance of persistently positive antiphospholipid antibodies (aPLs) remains incompletely defined. Objectives: ...
Letter to the editor - Re: Pereira Portela et al., Thromb. Res. 2026 (10.1016/j.thromres.2026.109683) comments on thrombin generation in compensated cirrhosis [0.03%]
读者来信-关于Pereira Portela等人的文章《 thromb res 2026 (10.1016/j.thromres.2026.109683)》对代偿期肝硬化的凝血酶生成的评论
Rawan Alhamami,Amir L Butt,Kenichi A Tanaka
Rawan Alhamami
Prevalence of iron deficiency in reproductive-age females on anticoagulation [0.03%]
口服抗凝血药物的育龄妇女铁缺乏症患病率
Brianna R Bakow,Rebecca L Zon,Shreya Agarwal et al.
Brianna R Bakow et al.
The use of anticoagulation in reproductive-aged females increases the risk of heavy menstrual bleeding (HMB). Excessive blood loss from HMB can lead to iron deficiency (ID), without or with anemia (IDA). We investigated the frequency with w...
Who says "no" - Patient-specific risk factors for refusal of venous thromboembolism chemoprophylaxis in hospitalized patients [0.03%]
患者拒绝接受住院静脉血栓栓塞化学预防的特异性风险因素分析
Anitha Ramadoss,Sydney Graboyes-Griffin,Jeremiah J Duby et al.
Anitha Ramadoss et al.
Background: Venous thromboembolism (VTE) increases morbidity and mortality for hospitalized patients. VTE chemoprophylaxis mitigates the risk of VTEs; however, missed doses are common. The purpose of this study was to inv...
Diverse antiphospholipid syndromes and beyond: A multicenter comprehensive analysis from the Egyptian College of Rheumatology [0.03%]
埃及风湿病学学院多中心综合分析：多样的抗磷脂综合征及其他问题
Noha A Azab,Eman I ElGazzar,Samar Tharwat et al.
Noha A Azab et al.
Background: Antiphospholipid syndrome (APS) is a complex autoimmune thrombo-inflammatory disorder characterized by diverse clinical manifestations and heterogeneous antibody profiles. We aimed to characterize the demograp...
Risk of venous thromboembolism in first-degree relatives of affected patients compared with general population [0.03%]
静脉血栓栓塞症患者的直系亲属的发病风险与普通人群对比研究
Sara Robin,Alice Nau,Eloïse Laouenan et al.
Sara Robin et al.
Background: Determining venous thromboembolism (VTE) risk among first-degree relatives (FDRs) of VTE patients requires effective risk assessment. We aimed to evaluate VTE risk in FDRs of index cases (ICs) compared to the ...
Aspirin dose, urinary thromboxane and prostacyclin metabolites, and clinical outcome in acute coronary syndrome: A nested case-control study from CURRENT-OASIS 7 [0.03%]
急性冠脉综合征的阿司匹林剂量、尿TXB2和PGI2代谢产物及临床结局：来至CURRENT-OASIS 7的事后队列病例对照研究
John W Eikelboom,Shamir R Mehta,Qilong Yi et al.
John W Eikelboom et al.
Background: Aspirin reduces urinary thromboxane, which predicts major adverse cardiovascular events (MACE) during aspirin therapy. However, in CURRENT-OASIS 7, higher-dose aspirin did not improve outcomes compared with lo...
Cytochalasins modulate donor responsiveness in functional assays for heparin-induced thrombocytopenia [0.03%]
细胞劈核酸改变供体对肝素诱导的血小板减少功能试验阳性的反应性
Minghai Li,Atsushi Yasumoto,Takayuki Usami et al.
Minghai Li et al.
Background: Functional assays are essential for confirming platelet-activating anti-PF4/heparin antibodies in heparin-induced thrombocytopenia (HIT), yet their performance is limited by procedural complexity and donor var...
Frailty and venous thromboembolism in older adults: Biological links and translational opportunities for risk stratification (narrative review) [0.03%]
老年人脆弱性与静脉血栓栓塞症的生物学关联及风险分层的转化机遇（叙述性回顾）
Diego Arauna,Simón Navarrete,Francisco J Garcia-Garcia et al.
Diego Arauna et al.
Introduction: Frailty is a geriatric syndrome characterized by reduced physiological reserve and increased vulnerability to stressors. Frailty overlaps with risk factors for deep vein thrombosis (DVT) and venous thromboem...
Prognostic indicators in VA-ECMO: Insights from thromboinflammatory markers [0.03%]
VA-ECMO预后的标志物：来自血栓炎症标志物的启示
Shengqiang Pei,Jie Xu,Zixin Chen et al.
Shengqiang Pei et al.
Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a life-saving intervention for refractory cardiogenic shock but is frequently complicated by thromboinflammation, leading to high morbidity and mo...